Abstract
In two patients with osteoporosis, systemic mastocytosis ultimately turned out to be the underlying disease. Both patients had a history of anaphylactic reactions caused by wasp stings but did not have any skin or other symptoms. This observation reflects the need for careful history taking and physical examination in patients with osteoporosis to identify possible underlying diseases, such as systemic mastocytosis.
Similar content being viewed by others
References
Taxel P, Kenny A (2000) Differential diagnosis and secondary causes of osteoporosis. Clin Cornerstone 2:11–21
Valent P, Horny HP, Escribano L, Longley BJ, Li CY, et al. (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603–625
Granerus G, Lonnqvist B, Nystrand J, Roupe G (1998) Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover. Br J Dermatol 139:858–861
Keyzer JJ, Wolthers BG, Muskiet FA, Kauffman HF, Groen A (1981) Determination of N-tau-methylhistamine in plasma and urine by isotope dilution mass fragmentography. Clin Chim Acta 113:165–173
Akin C, Metcalfe DD (2004) Systemic mastocytosis. Annu Rev Med 55:419–432
Valent P, Akin C, Sperr WR, Horny HP, Arock M, et al. (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122:695–717
Castells MC (2004) Mastocytosis: classification, diagnosis, and clinical presentation. Allergy Asthma Proc 25:33–36
Lim AY, Ostor AJ, Love S, Crisp AJ (2005) Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis 64:965–966
Valent P, Akin C, Sperr WR, Escribano L, Arock M, et al. (2003) Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 27:635–641
Chiappetta N, Gruber B (2006) The role of mast cells in osteoporosis. Semin Arthritis Rheum 36:32–36
Brumsen C, Papapoulos SE, Lentjes EG, Kluin PM, Hamdy NA (2002) A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone (NY) 31:556–561
Barbie DA, Deangelo DJ (2006) Systemic mastocytois: current classification and novel therapeutic options. Clin Adv Hematol Oncol 4:768–775
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Donker, M.L., Bakker, N.A., Jaspers, W.J.M. et al. Two patients with osteoporosis: initial presentation of systemic mastocytosis. J Bone Miner Metab 26, 199–202 (2008). https://doi.org/10.1007/s00774-007-0800-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-007-0800-x